Overview

Condition anemia
Sponsor University of California, Davis
Start date November 2012
End date November 2017
Trial size 70 participants
Trial identifier NCT01811342, 348788

Summary

Evaluate potential sources of error that affect the accuracy of continuous hemoglobin monitoring.

Recruiting in the following locations…

United States California
Other countries No locations recruiting

Study Design

Observational model case-only
Time perspective retrospective
Arm
Patients requiring intra-operative hemoglobin measurement.

Primary Outcomes

Measure
Evaluation of the Masimo Continuous Hemoglobin Monitor with Polar Plot Methodology
time frame: One year

Eligibility Criteria

All participants at least 18 years old.

Inclusion Criteria: - Patients undergoing elective surgery. Exclusion Criteria: - 0

Additional Information

Official title Evaluation of the Masimo Continuous Hemoglobin Monitor With Polar Plot Methodology
Trial information was received from ClinicalTrials.gov and was last updated in March 2017.
Information provided to ClinicalTrials.gov by University of California, Davis.